Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2025 Earnings Call Transcript
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2025 Earnings Call Transcript February 24, 2026 Day One Biopharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.21 EPS, expectations were $-0.17. Operator: Hello, ladies and gentlemen …